Bill C-224 primarily aims to incorporate natural health products into the regulatory framework of the Food and Drugs Act. This is intended to ensure that these products meet safety and efficacy standards comparable to those applied to drugs and other regulated health products.

Key provisions of the bill include clearly defining what constitutes a natural health product and establishing specific requirements for labeling, advertising, and manufacturing. It also provides for post-market surveillance mechanisms to detect and manage potential adverse effects.

The Food and Drugs Act will be amended to include new sections dedicated to natural health products, necessitating adjustments in existing regulations and the creation of new guidelines.

Manufacturers, distributors, and retailers of natural health products will be directly affected by these regulatory changes. Consumers will benefit from increased transparency and better health protection.